Benchling puts agent teams inside R&D workflows: in a recombinant protein foundry, agents draft the design, place the order, run instruments and write the report
At Benchtalk 2026, Benchling launched Science Foundries, where teams of AI agents work alongside scientists across a full R&D workflow rather than speeding up a single step. In a recombinant protein foundry, one agent drafts the cloning design, another orders from a CRO and calls Benchling Automation to run instruments, and an Analysis Agent writes the report, with a scientist signing off at every critical decision. The product is in preview for customers, and the company is building foundries with customers across target validation, screening, method development and biologics production.